Efficacy and safety of low-dose IL-2 (Id-IL-2) as a Treg enhancer for controlling neuro-inflammation in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients (MIROCALS)

Principal Investigators

Prof Nigel Leigh

Institution

University of Sussex

Contact information of lead PI

Country

United Kingdom

Title of project or programme

Efficacy and safety of low-dose IL-2 (Id-IL-2) as a Treg enhancer for controlling neuro-inflammation in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients (MIROCALS)

Source of funding information

MND Association

Total sum awarded (Euro)

429,029

Start date of award

01/09/2016

Total duration of award in years

Keywords

Research Abstract

Further information available at:

Types: Investments < €500k

Member States: United Kingdom

Diseases: N/A

Years: 2016

Database Categories: N/A

Database Tags: N/A

Export as PDF